Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The North America Endometrial Ablation Market would witness market growth of 4.8% CAGR during the forecast period (2018 ? 2024). Endometrial ablation is used in facilitating the destruction of endometrium or thin layer of the uterine wall, and is used in treating abnormal heavy uterine bleeding. Prolonged abnormal uterine bleeding could lead to low blood count and anemia. Endometrial ablation is a technique that has gained prominence as there is no need for incisions, and the technique is very popular among women suffering menstrual problems. Growing awareness about endometrial ablation technology and growing cases of menorrhagia, well-developed healthcare infrastructure, and a strong business landscape with leading players contributing to the market growth.
Based on the Technology, the Endometrial Ablation market is segmented into Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, and Others. Based on the end user, the market is segmented into Hospitals, Clinics, and Ambulatory Surgical Centers. Based on countries, the Endometrial Ablation market segments the market into US, Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the North America Endometrial Ablation Market. Key companies profiled in the report include are Smith & Nephew Plc, Olympus Corporation, Boston Scientific Corporation, Karl Storz GmbH & Co. KG, Ethicon, LLC. (Johnson & Johnson), Medtronic Plc, Hologic Corporation, Minerva Surgical, Inc., The Cooper Companies, Inc. (Cooper Surgical Inc.), and AngioDynamics Inc.